Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Endocrinology · Type A Insulin Resistance Syndrome

The Biology of TAIRS: Genes, Receptors, and Look-Alikes

At a Glance

Type A insulin resistance syndrome (TAIRS) usually results from an inherited INSR mutation that disrupts insulin-receptor signaling. It can cause severe insulin resistance despite a lean build and resemble PCOS, so genetic testing can clarify the diagnosis and inheritance.

Understanding the biology of Type A Insulin Resistance Syndrome (TAIRS) helps explain why your body behaves differently than someone with more common metabolic conditions. While many people think of insulin resistance as a single problem, it is actually a spectrum of different biological issues [1].

The Impaired Lock: How INSR Mutations Work

To understand TAIRS, it helps to think of your cells as having “locks” (receptors) and insulin as the “key.” In a typical body, the key fits into the lock, turns, and opens a door to let sugar (glucose) into the cell for energy.

The insulin receptor is made of two main parts:

  1. The Alpha Subunit: The outer part of the “lock” that catches the insulin “key” [2].
  2. The Beta Subunit: The inner part of the “lock” that acts like an engine (tyrosine kinase) to send signals inside the cell [3].

In TAIRS, a mutation in the INSR gene means these locks are impaired or unable to properly send a signal [4][5]. Even though your body might produce a massive amount of insulin, the “doors” to your cells resist opening. This is why you can have extremely high insulin levels but still have high blood sugar [4].

The Spectrum of INSR Disorders

TAIRS is part of a family of conditions called INSR-related insulin resistance syndromes. These disorders exist on a spectrum based on how much receptor function is lost, though severity is not completely determined by genetics alone [1].

  • Donohue Syndrome (formerly Leprechaunism): This is classically the most severe form, usually caused by having two impaired copies of the gene (biallelic). It affects infants from birth, causing significant growth issues and very severe metabolic distress [1][6].
  • Rabson-Mendenhall Syndrome: This is a middle-ground form. It usually appears in early childhood and includes severe insulin resistance along with unique features like dental abnormalities and thickened skin [7].
  • Type A Insulin Resistance (TAIRS): This is generally the “mildest” form on this specific spectrum, though “mild” is relative—it still involves profound insulin resistance. It most often appears around puberty and is classically caused by having just one mutated copy of the gene (heterozygous) [8][9].

TAIRS vs. Common Look-Alikes

Because its symptoms—like acne, irregular periods, and ovarian cysts—are so common, TAIRS is frequently misdiagnosed. However, the biology behind it is very different from its “look-alikes.”

TAIRS vs. Polycystic Ovary Syndrome (PCOS)

While they look similar on the surface, they are distinct at the cellular level, though it is crucial to understand that TAIRS and PCOS can coexist:

  • Cause: TAIRS is caused by a single, specific genetic mutation (Mendelian). PCOS is a complex condition caused by a mix of many genes and environmental factors [10][11].
  • Insulin Levels: While people with PCOS often have insulin resistance, the levels in TAIRS are typically marked by severe hyperinsulinemia that is disproportionate to body weight [4][8].
  • Body Type: PCOS is often (but not always) associated with weight gain. TAIRS typically occurs in people who are lean or have a very athletic build [12]. Even when TAIRS is confirmed, coexisting symptoms like absent periods still require independent evaluation to protect the uterine lining.

TAIRS vs. Type B Insulin Resistance

It is easy to confuse “Type A” and “Type B,” but they have completely different origins:

  • Type A (Genetic): You are born with the mutation. It usually shows up in your teens and is a permanent part of your genetic makeup [8].
  • Type B (Autoimmune): This is an “acquired” condition, meaning it starts later in life (usually in older adults). It is caused by the immune system mistakenly attacking the insulin receptors with autoantibodies [13][14]. It is often linked to other autoimmune diseases like Lupus [15].

Why Your Specific Mutation Matters

Genetic testing can identify exactly where your “lock” is impaired. Some mutations prevent the receptor from ever reaching the cell surface, while others allow the receptor to sit there but prevent it from “turning” to send a signal [4][2]. Knowing your specific genotype helps your doctors understand if your condition follows a dominant or recessive pattern, which is vital for understanding your own health and that of your family members [16].

Common questions in this guide

What causes Type A insulin resistance syndrome?
TAIRS is usually caused by an inherited change in the INSR gene, which provides instructions for the insulin receptor. The altered receptor may fail to reach the cell surface or may be unable to pass insulin’s signal into the cell, so the body can produce very high insulin levels while blood sugar remains high.
How is TAIRS different from PCOS?
TAIRS is usually linked to a single INSR gene mutation, whereas PCOS results from a complex mix of genetic and environmental factors. TAIRS often causes unusually severe high insulin levels in a lean person, but TAIRS and PCOS can occur together, so menstrual or ovarian symptoms may need separate evaluation.
What is the difference between Type A and Type B insulin resistance?
Type A insulin resistance is inherited and usually becomes noticeable around puberty. Type B is acquired later, often in older adults, when immune proteins called autoantibodies interfere with insulin receptors; it may be associated with autoimmune diseases such as lupus.
What can genetic testing reveal about TAIRS?
Genetic testing can identify the specific INSR change and whether it affects the receptor’s outer alpha part or inner signaling beta part. It can also help clarify whether the variant follows a dominant or recessive inheritance pattern, which may matter for relatives.
When do symptoms of TAIRS usually begin?
TAIRS most often becomes apparent around puberty, although the exact timing and severity vary. Acne, excess hair growth, irregular or absent periods, ovarian cysts, and severe insulin resistance can resemble PCOS and may prompt further evaluation.
How does TAIRS fit with Donohue syndrome and Rabson-Mendenhall syndrome?
These conditions are part of a spectrum of INSR-related insulin resistance disorders defined by how much insulin-receptor function is lost. Donohue syndrome is generally the most severe and begins in infancy, Rabson-Mendenhall syndrome is intermediate, and TAIRS is generally the milder end of this spectrum, although TAIRS can still cause profound insulin resistance.

Get notified when new evidence is published on Insulin-resistance syndrome type A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    A novel homozygous missense mutation in the insulin receptor gene results in an atypical presentation of Rabson-Mendenhall syndrome.

    Ben Abdelaziz R, Ben Chehida A, Azzouz H, et al.

    European journal of medical genetics 2016; (59(1)):16-9.

    PMID: 26691667
  2. 2

    Structure and function of the insulin receptor-a personal perspective.

    Kasuga M

    Proceedings of the Japan Academy. Series B, Physical and biological sciences 2019; (95(10)):581-589 doi:10.2183/pjab.95.039.

    PMID: 31827016
  3. 3

    Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated diseases.

    Tsuji-Hosokawa A, Takasawa K, Nomura R, et al.

    Pediatric diabetes 2017; (18(8)):917-924 doi:10.1111/pedi.12508.

    PMID: 28181734
  4. 4

    A New Mutation of the INSR Gene in a 13-Year-Old Girl with Severe Insulin Resistance Syndrome in China.

    Jin J, Liang X, Wei J, Xu L

    BioMed research international 2021; (2021()):8878149 doi:10.1155/2021/8878149.

    PMID: 33728347
  5. 5

    Severe insulin resistance in disguise: A familial case of reactive hypoglycemia associated with a novel heterozygous INSR mutation.

    Innaurato S, Brierley GV, Grasso V, et al.

    Pediatric diabetes 2018; (19(4)):670-674 doi:10.1111/pedi.12632.

    PMID: 29411486
  6. 6

    A case of Donohue syndrome "Leprechaunism" with a novel mutation in the insulin receptor gene.

    Kirel B, Bozdağ Ö, Köşger P, et al.

    Turk pediatri arsivi 2017; (52(4)):226-230 doi:10.5152/TurkPediatriArs.2017.3193.

    PMID: 29483803
  7. 7

    Rabson-Mendenhall Syndrome: Analysis of the Clinical Characteristics and Gene Mutations in 42 Patients.

    Gong W, Chen W, Dong J, Liao L

    Journal of the Endocrine Society 2024; (8(8)):bvae123 doi:10.1210/jendso/bvae123.

    PMID: 38957655
  8. 8

    Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report.

    Lin L, Chen C, Fang T, et al.

    Journal of medical case reports 2019; (13(1)):347 doi:10.1186/s13256-019-2304-4.

    PMID: 31771632
  9. 9

    Homozygous Mutation in the Insulin Receptor Gene Associated with Mild Type A Insulin Resistance Syndrome: A Case Report

    Hacıhamdioğlu B, Baş EG, Delil K

    Journal of clinical research in pediatric endocrinology 2020; (13(1)):100-103 doi:10.4274/jcrpe.galenos.2020.2019.0213.

    PMID: 32018348
  10. 10

    New classification and diagnostic criteria for insulin resistance syndrome.

    Ogawa W, Araki E, Ishigaki Y, et al.

    Endocrine journal 2022; (69(2)):107-113 doi:10.1507/endocrj.EJ21-0725.

    PMID: 35110500
  11. 11

    Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification.

    Dapas M, Dunaif A

    Endocrine reviews 2022; (43(6)):927-965 doi:10.1210/endrev/bnac001.

    PMID: 35026001
  12. 12

    A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a De Novo INSR c.3328G>C mutation.

    Ji C, Zheng X, Wang Q, Chen Z

    Frontiers in endocrinology 2026; (17()):1840942 doi:10.3389/fendo.2026.1840942.

    PMID: 42272804
  13. 13

    Type B insulin resistance syndrome.

    Willard DL, Stevenson M, Steenkamp D

    Current opinion in endocrinology, diabetes, and obesity 2016; (23(4)):318-23 doi:10.1097/MED.0000000000000263.

    PMID: 27254267
  14. 14

    Clinical characteristics of insulin resistance syndromes: A nationwide survey in Japan.

    Takeuchi T, Ishigaki Y, Hirota Y, et al.

    Journal of diabetes investigation 2020; (11(3)):603-616 doi:10.1111/jdi.13171.

    PMID: 31677333
  15. 15

    Type B insulin resistance syndrome: a systematic review.

    Martins LM, Fernandes VO, Carvalho MMD, et al.

    Archives of endocrinology and metabolism 2020; (64(4)):337-348 doi:10.20945/2359-3997000000257.

    PMID: 32813762
  16. 16

    Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation

    Poon SWY, Chung BHY, Wong MSC, Tsang AMC

    Journal of clinical research in pediatric endocrinology 2025; (17(1)):115-119 doi:10.4274/jcrpe.galenos.2023.2022-12-10.

    PMID: 37074094

This page is for informational purposes only and does not constitute medical advice. Your endocrinologist or clinical geneticist should interpret your INSR results and guide testing, monitoring, and care.